AtomoRapid Archives - Atomo Diagnostics

24 Sep PRESS RELEASE: Mylan Extends Commitment to Fight HIV/AIDS by Partnering with Atomo Diagnostics to Expand Access to HIV Self-Testing in Low- and Middle-Income Countries

Posted at 09:24h in Press Release by TXk4s1wBDi 0 Comments

0 Likes

HERTFORDSHIRE, England, PITTSBURGH and SYDNEY, September 24, 2018 – Global pharmaceutical company Mylan N.V.(NASDAQ: MYL) and medical device company Atomo Diagnostics today announced a strategic partnership to commercialize CE-Marked in vitro HIV rapid diagnostic tests for self-testing in low- and middle-income countries. The tests will allow...

05 Jun Strategic Partnership Announcement: Atomo Diagnostics and Owen Mumford

Posted at 14:43h in News by TXk4s1wBDi 0 Comments

0 Likes

Today, Atomo Diagnostics and Owen Mumford Ltd announced a strategic partnership for commercialisation of innovative HIV rapid tests in European markets Owen Mumford is a major healthcare company and device manufacturer that commercialises pioneering medical products in its own brand to enhance access to diagnostics, encourage...

05 Jun PRESS RELEASE: Atomo Diagnostics and Owen Mumford partner to introduce best-in-class HIV rapid testing in European markets

Posted at 14:30h in Press Release by TXk4s1wBDi 0 Comments

0 Likes

Sydney, Australia and Woodstock, England – 05 June 2018 | Atomo Diagnostics and Owen Mumford Ltd have today announced a strategic partnership for commercialisation of innovative HIV rapid tests in European markets Owen Mumford acquires exclusive rights to Atomo’s HIV rapid tests for commercialisation under...

20 Feb JOINT PRESS ANNOUNCEMENT: RPS Diagnostics partners with Atomo Diagnostics

Posted at 10:41h in Press Release by TXk4s1wBDi 0 Comments

0 Likes

RPS Diagnostics partners with Atomo Diagnostics to develop next generation FebriDx blood tests for antibiotic stewardship in the outpatient setting Sarasota, Florida and Sydney, Australia (February 20, 2018) – United States biotechnology company, RPS Diagnostics (RPS®), and Australian medical device company, Atomo Diagnostics, announced today that...

23 Jan Strategic Partnership Announcement: Atomo Diagnostics and Access Bio

Posted at 00:24h in News by TXk4s1wBDi 0 Comments

0 Likes

Today, Atomo Diagnostics and Access Bio Inc. jointly announced a strategic partnership to leverage the respective strengths of both companies and expand point of care HIV testing in global markets. Atomo will supply its award-winning AtomoRapid™ lateral flow diagnostic test platforms for use with Access Bio’s in vitro HIV rapid...

23 Jan PRESS RELEASE: Atomo Diagnostics and Access Bio partner to expand access to best-in-class HIV rapid testing in global markets

Posted at 00:01h in Press Release by TXk4s1wBDi 0 Comments

0 Likes

Sydney, Australia and Seoul, South Korea – 23 January 2018 | Atomo Diagnostics and Access Bio Inc. today announce a strategic partnership to leverage the respective strengths of both innovative rapid diagnostic test (RDT) companies to expand point of care HIV testing in global markets. ...

01 Dec World AIDS Day 2017: Self-testing key to improving early diagnosis of HIV

Posted at 09:13h in Blog by TXk4s1wBDi 0 Comments

0 Likes

Written by CEO, John Kelly: As I read the news, on this World AIDS Day, I am heartened to see so many positive and inspiring stories about the progress being made in communities around the world in the ongoing fight against HIV/AIDS. Nonetheless, it is clear...

15 Nov Atomo creates a buzz at Medica 2016

Posted at 09:10h in Blog by TXk4s1wBDi 0 Comments

0 Likes

Written by John Kelly, CEO at Atomo Diagnostics: Medica is one of those events that I look forward to every year, and my team and I have been coming here for many years! It’s a chance to meet up with friends and contacts, and to talk...